RCUS

Arcus Biosciences INC

-$400.1M

Net Activity

Institutions Holding

210

Popularity Rank

#2768

Avg Weight

0.28%

Total Value

$2.6B

Ownership Trend

210 institutions currently hold RCUS, with 115 net buyers and 90 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

90

Net Buying Institutions

115

Key Holders

View all 210 holding institutions

Quarterly Activity

Recent Activity

+$1.2B

Total Buy Value

$765.8M

Total Sell Value

New buy30
Trim56
Add85
Sold out34

115

Net Buyers

90

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

3

Filings (90d)

$2.87M

Total Est. Value

100K shares

Planned Shares

Last Filed 2026-07-09
FilerFiling DateEst. Value
Juan Jaen2026-07-09$749K
Jaen Juan C.2026-06-24$1.44M
Jaen Juan C.2026-06-22$681K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ARCUS BIOSCIENCES INC (RCUS)?
Major stakeholders currently include Gilead Sciences, INC. ($678.8M), BlackRock, Inc. ($328.9M), Wellington Management Group LLP ($131.5M). Based on the latest 13F filings, there are a total of 210 tracked investment funds and institutions maintaining positions in RCUS.
What is the overall institutional sentiment toward RCUS recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $400.1M, driven by 115 managers accumulating shares while 90 reduced their exposure.
Which institutions have been selling or reducing their RCUS positions?
In the latest period, 56 funds trimmed their holdings, and 34 managers completely exited their positions. The aggregate reported sell value was $765.8M.
Are there any notable investors adding RCUS to their portfolios?
Yes, buying activity remains notable. 30 institutions opened new positions in {ticker}, and 85 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.2B.

Related Stocks